Trade MerckCo USA ^MRK

Apollon Wealth Management LLC Purchases 46,936 Shares of Merck & Co., Inc. $MRK

Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Merck & Company (MRK)

Merck & Co., Inc. $MRK Stake Boosted by Norris Perne & French LLP MI - Markets Daily

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

Merck & Co., Inc. $MRK Stock: Valley National Advisers Inc. Lowers Holdings

Merck & Co., Inc. $MRK Position Trimmed by Middleton & Co. Inc. MA

Merck & Co., Inc. $MRK Stock: Mondrian Investment Partners LTD Cuts Holdings

Merck & Co., Inc. $MRK Stock Sold by Carolina Wealth Advisors LLC

Merck & Co., Inc. $MRK Stock Bought by Norris Perne & French LLP MI - Stock Observer

Evergreen Capital Management LLC Sells 69,731 Shares of Merck & Co., Inc. $MRK

BG Investment Services LLC Makes New $5.39 Million Investment in Merck & Co., Inc. $MRK

17,497 Merck & Co., Inc. $MRK Shares Acquired by Bernardo Wealth Planning LLC

Merck & Co., Inc. $MRK Holdings Decreased by Sterling Capital Management LLC - Stock Observer

Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

Merck & Co., Inc. $MRK Stock Sold by Capital Investment Advisors LLC

Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial

Interpath-100: data leak, stock drop, spirited defense by ESMO president

Merck & Co., Inc. $MRK Stock: Investment House LLC Reduces Position

Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market

Moderna, Inc. (NASDAQ:MRNA) Stock Has Consensus Target Price of $101.45 According to Analysts - Stock Observer

Oncologists cheer melanoma data that tanked Moderna's shares | News & Features | ArcaMax Publishing

Moderna, Merck shares fall on eagerly anticipated cancer vaccine results

Moderna, Merck Shares Fall After Possible Melanoma Data Leak

6,761 Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas

Top Pharmaceutical Stocks To Add to Your Watchlist - October 22nd - Daily Political

Merck & Co., Inc. $MRK Stock Sold by Inlet Private Wealth LLC

Merck & Co., Inc. $MRK Stock Sold by Crossmark Global Holdings Inc.

Merck & Co., Inc. $MRK Shares Purchased by Diversify Advisory Services LLC

Merck & Co., Inc. (MRK) Set to Release Earnings on Thursday

Merck & Co., Inc. $MRK Stock Holdings Lowered by Cantor Fitzgerald Investment Advisors L.P.

27,739 Merck & Co., Inc. $MRK Shares Sold by Axxcess Wealth Management LLC

Merck & Co., Inc. $MRK Stock Sold by Smith Chas P & Associates PA Cpas - Daily Political

Small Cell Lung Cancer Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of Administration Trends | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca | ABNewswire

Merck & Co., Inc. $MRK Stock Sold by Robeco Institutional Asset Management B.V.

Merck & Co., Inc. (NYSE:MRK) Cut to "Strong Sell" at Zacks Research

6,860 Merck & Co., Inc. $MRK Shares Sold by QV Investors Inc.

Merck & Co., Inc. $MRK Stock Sold by Nisa Investment Advisors LLC

119,254 Merck & Co., Inc. $MRK Shares Sold by Robeco Institutional Asset Management B.V. - Stock Observer

Bank Pictet & Cie Europe AG Sells 42,242 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. (NYSE:MRK) Rating Lowered to Strong Sell at Zacks Research - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Stock Rating Cut to Strong Sell at Zacks Research - Stock Observer

RBC Capital Reaffirms Their Hold Rating on Sanofi (SNYNF)

RBC Capital Remains a Buy on Eli Lilly & Co (LLY)

Dow leads Wall Street higher, investors focus on healthcare stocks

Merck & Co., Inc. $MRK Stock: Willis Investment Counsel Cuts Holdings

74,700 Merck & Co., Inc. $MRK Shares Sold by Willis Investment Counsel - Stock Observer

64,996 Merck & Co., Inc. $MRK Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd - Daily Political

RBC Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

AbbVie (ABBV) Receives a Buy from RBC Capital

Merck & Co., Inc. $MRK Position Boosted by Fairvoy Private Wealth LLC

How Investors Are Reacting To Merck (MRK) Phase 3 Melanoma Results

Merck & Co., Inc. $MRK Stock Sold by BDF Gestion - Markets Daily

Merck & Co., Inc. $MRK Stock: BDF Gestion Decreases Holdings - Zolmax

13,487 Merck & Co., Inc. $MRK Shares Sold by Generali Investments Management Co LLC

Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer

Merck & Co., Inc. $MRK Stock: Birch Hill Investment Advisors LLC Cuts Holdings

Merck & Co., Inc. $MRK Stock: 1834 Investment Advisors Co. Decreases Position

Kintegral Advisory LLC Buys New Holdings in Moderna, Inc. $MRNA - Stock Observer

Healthcare Stocks To Consider - October 17th - Markets Daily

Merck & Co., Inc. $MRK Stock: Hengehold Capital Management LLC Reduces Position

TD Waterhouse Canada Inc. Purchases 131,302 Shares of Merck & Co., Inc. $MRK

4,916 Merck & Co., Inc. $MRK Shares Sold by Cyndeo Wealth Partners LLC - Zolmax

Merck & Co., Inc. $MRK Shares Sold by Cantor Fitzgerald Investment Advisors L.P. - Markets Daily

Merck & Co., Inc. $MRK Stock: Cantor Fitzgerald Investment Advisors L.P. Cuts Position

Merck & Co., Inc. $MRK Shares Sold by Cyndeo Wealth Partners LLC - Daily Political

Merck & Co., Inc. $MRK Stock: Banque Pictet & Cie SA Cuts Holdings

RBC Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)

Eli Lilly & Co (LLY) Receives a Buy from RBC Capital

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

RBC Capital Reaffirms Their Hold Rating on Pfizer (PFE)

AbbVie vs. Merck: Which Pharma Stock Offers Better Value?

Insider Selling: Moderna (NASDAQ:MRNA) President Sells $8,640,084.40 in Stock - Stock Observer

Merck's Rally Reflects Renewed Confidence, but Has the Market Priced in Too Much? - Insider Monkey

Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer

Milestone Asset Management LLC Sells 9,248 Shares of Merck & Co., Inc. $MRK

NFSG Corp Buys 4,100 Shares of Merck & Co., Inc. $MRK - Markets Daily

NFSG Corp Purchases 5,162 Shares of Moderna, Inc. $MRNA - Markets Daily

8,527 Shares of Merck & Co., Inc. $MRK Acquired by Neumann Capital Management LLC

18,326 Merck & Co., Inc. $MRK Shares Sold by Ninety One UK Ltd

Merck & Co., Inc. $MRK Stock: State of Alaska Department of Revenue Reduces Stake

Merck & Co., Inc. $MRK Stock Sold by Community Trust & Investment Co. - Zolmax

1,133,024 Merck & Co., Inc. $MRK Shares Sold by Assenagon Asset Management S.A.

Moderna, Inc. $MRNA Position Lifted by NFSG Corp - Stock Observer

8,294 Merck & Co., Inc. $MRK Shares Sold by State of Alaska Department of Revenue - Daily Political

Reviewing ABVC BioPharma (NASDAQ:ABVC) & Merck & Co., Inc. (NYSE:MRK) - Daily Political

Moderna (NASDAQ:MRNA) Shares Up 4.5% Following Analyst Upgrade

PFG Private Wealth Management LLC Makes New Investment in Moderna, Inc. $MRNA - Zolmax

Pharmaceutical Stocks To Keep An Eye On - October 15th - Zolmax

Merck & Co., Inc. (MRK) Reports Promising Skin Cancer Trial Results for Keytruda and Personalized mRNA Vaccine

Merck & Co., Inc. $MRK Stock: Fort Washington Investment Advisors Inc. OH Decreases Holdings - Zolmax

VMS Asset Management Limited Makes New Investment in Merck & Co., Inc. $MRK